The Food and Drug Administration on Thursday approved an Alnylam Pharmaceuticals medicine for a serious heart condition, a decision that should help the biotechnology firm secure its position as one ...

Cantor Fitzgerald analyst Andres Sheppard upgrades Tesla from Neutral to Overweight and maintains a price target of $425. "Overall we are bullish after our factory visit, and after the recent ...